Bioinformatics analysis reveals four major hexon variants of human adenovirus type-3 (HAdV-3) as the potential strains for development of vaccine and siRNA-based therapeutics against HAdV-3 respiratory infections

Human adenovirus type 3 (HAdV-3) encompasses 15–87% of all adenoviral respiratory infections. The significant morbidity and mortality, especially among the neonates and immunosuppressed patients, demand the need for a vaccine or a targeted antiviral against this type. However, due to the existence o...

Full description

Saved in:
Bibliographic Details
Published in:Infect Genet Evol
Main Authors: Panda, Somnath, Banik, Urmila, Adhikary, Arun K.
Format: Artigo
Language:Inglês
Published: The Authors. Published by Elsevier B.V. 2020
Subjects:
Short Communication
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7308778/
https://ncbi.nlm.nih.gov/pubmed/32585339
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.meegid.2020.104439
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items